Poludan® (Poludanum®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsplyophilizate for the preparation of nasal drops
Composition:

Polyriboadenyl acid potassium salt (potassium polyriboadenylate) 0.1 mg, polyribouridic acid potassium salt (potassium polyribouridilate) 0.107 mg;

Excipients: sodium hydrogen phosphate (sodium phosphate 2-substituted) 2.0 mg, potassium dihydrogen phosphate (potassium phosphate 1-substituted anhydrous) 0.408 mg, sodium chloride 8.5 mg.

Description:

Liofilizate white.

Pharmacotherapeutic group:immunostimulating agent
ATX: & nbsp
  • Antiviral drugs
    • Pharmacodynamics:

    Poludan is a biosynthetic polyribonucleotide complex of polyriboadenyl and polyribouridyl acids. Inductor synthesis of endogenous interferon and other cytokines. Stimulates the formation of mainly alpha-interferon, to a lesser extent beta and gamma-interferon. It induces the synthesis of interferon in peripheral blood leukocytes, as well as in tissues and organs containing lymphoid elements. A high level of interferon is maintained by daily administrations throughout the course. Has a direct antiviral effect against influenza viruses and other acute respiratory viral infections. Modulates the cytokine response when the cells are infected with a virus.

    Indications:

    Treatment of influenza and other acute respiratory viral infections.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Dosing and Administration:

    Locally.

    The drug is used in adults for the treatment of influenza and other acute viral respiratory infections in the form of drops in the nose. Bury 2 drops in each nostril 5 times a day for 5 days in the acute period of the disease - no later than 24-48 hours after the first symptoms appear.

    A solution of Poludan is prepared by dissolving the contents of the vial (100 units) with boiled water until the label shown on the label.

    Side effects:

    Allergic reactions are rare.

    Interaction:

    With the simultaneous use of Poludan® with enzyme preparations due to the destructive action of enzymes on endogenous interferon, the clinical efficacy of Poludan® decreases.

    Compatible with antibiotics and medicines for the treatment of viral infections.

    Special instructions:

    Adverse events are transitory in nature and disappear after discontinuation of the drug after 1-3 days.

    Form release / dosage:

    Liofilizate for the preparation of nasal drops, 100 units.

    Packaging:

    100 ED in flasks of colorless glass.

    1 or 3 bottles complete with 1 or 3 dropper caps and instructions for use in a pack of cardboard.

    Storage conditions:

    In the dark place at a temperature of no higher than 8 ° C.

    Keep out of the reach of children.

    Shelf life:

    4 years.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-002184
    Date of registration:12.03.2012 / 14.11.2014
    The owner of the registration certificate:LENS-PHARM, LLC LENS-PHARM, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp11.02.2016
    Illustrated instructions
      Instructions
      Up